Platelet serotonin concentration and monoamine oxidase activity in hypothyroid patients

Hormone Research

Volumn 71, Issue 4, 2009, Pages 207-212

  Stipcevic, Tamara ^a,b   Kusacic Kuna, Sanja ^a   Dezeljin, Martina ^a   Dodig, Damir ^a   Korsic, Mirko ^a   Pivac, Nela ^a   Muck Seler, Dorotea ^a  

^a KBC Zagreb   (Croatia)

^b NONE   (Croatia)

Author keywords

5 Hydroxytryptamine, platelet; Hypothyroidism; Monoamine oxidase B, platelet; Thyroid stimulating hormone; Thyroxine

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; SEROTONIN; THYROTROPIN; THYROXINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FLUOROIMMUNOASSAY; FOLLOW UP; HUMAN; HYPOTHYROIDISM; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SPECTROFLUOROMETRY; THROMBOCYTE; THYROID CARCINOMA; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

ADULT; AGED; BLOOD PLATELETS; FEMALE; HUMANS; HYPOTHYROIDISM; MIDDLE AGED; MONOAMINE OXIDASE; SEROTONIN; SUBSTANCE WITHDRAWAL SYNDROME; THYROTROPIN; THYROXINE;

EID: 61349185136     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000201109     Document Type: Article

References (51)

1. Ahmed OM, El-Gareib AW, El-bakry AM, El-Tawab SMA, Ahmed RG: Thyroid hormones states and brain development interactions. Int J Dev Neurosci 2008;26:147-209.
2. Bauer M, Heinz A, Whybrow PC: Thyroid hormones, serotonin and mood: of synergy and significance in the adult brain. Mol Psychiatr 2002;7:140-156.
3. Sandrini M, Vitale G, Vergoni AV, Ottani A, Bertolini A: Effect of acute and chronic treatment with triiodothyronine on serotonin levels and serotonergic receptor subtypes in the rat brain. Life Sci 1996;58:1551-1559.
4. Strawn JR, Ekhator NN, D'Souza BB, Geraciotti TD, Geraciotti JR: Pituitary-thyroid state correlates with central dopaminergic and serotonergic activity in healthy humans. Neuropsychobiology 2004;49:84-87.
5. Newman M, Agid O, Gur E, Lerer B: Pharmacological mechanisms of T3 augmentation of antidepressant action. International J Neuropsychopharmacol 2003;3:187-191.
6. Viquerie N, Langin D: Effects of thyroid hormone and gene expression. Curr Opin Clin Nutr Metab Care 2003;6:377-381.
7. Singhal RL, Rastogi RB, Hrdina PD: Brain biogenic amines and altered thyroid function. Life Sci 1975;17:1617-1626.
8. Ito JM, Valcana T, Timiras PS: Effect of hypo- and hyperthyroidism on regional monamine metabolism in the adult rat brain. Neuroendocrinology 1977;24:55-64.
9. Savard P, Merand Y, DiPaolo T, Dupont A: Effect of neonatal hypothyroidism on the serotonin system of the rat brain. Brain Res 1984;292:99-108.
10. Henley WN, Chen X, Klettner C, Bellush LL, Notestine MA: Hypothyroidism increases serotonin turnover and sympathetic activity in the adult rat. Can J Physiol Pharmacol 1991;69:205-210.
11. Vanderpump MP, Tunbridge WM: Epidemiology and prevention of clinical and subclinical hypothyroidism. Thyroid 2002;12:839-847.
12. Forman-Hoffman V, Philibert RA: Lower TSH and higher T4 levels are associated with current depressive syndrome in young adults. Acta Psychiatr Scand 2006;114:132-139.
13. Łojko D, Rybakowski JK: L -Thyroxine augmentation of serotonergic antidepressants in female patients with refractory depression. J Affect Disord 2007;103:253-256.
14. Sjöberg S, Eriksson M, Nordin C: L -Thyroxine treatment and neurotransmitter levels in the cerebrospinal fluid of hypothyroid patients: a pilot study. Eur J Endocrinol 1998;139:493-497.
15. Cleare AJ, McGregor A, Keane VO: Neuroendocrine evidence for an association between hypothyroidism, reduced central 5-HT activity and depression. Clin Endocrinol 1995;43:713-719.
16. Kulikov A, Moreau X, Jeanningros R: Effects of experimental hypothyroidism on 5-HT1A, 5-HT2A receptors, 5-HT uptake sites and tryptophan hydroxylase activity in mature rat brain. Neuroendocrinology 1999;69:453-459.
17. Nemeroff CB: Recent advances in the neurobiology of depression. Psychopharmacol Bull 2002;36:6-23.
18. Moorley JE: Neuroendocrine control of thyrotropin secretion. Endocr Rev 1981;2:396-436.
19. Howland RH: Thyroid dysfunction in refractory depression: implications for pathophysiology and treatment. J Clin Psychiatry 1993;54:47-54.
20. Nemeroff CB: Clinical significance of psychoneuroendocrinology in psychiatry: focus on the thyroid and adrenal. J Clin Psychiatry 1989;50:13-20.
21. Prange AJ, Wilson IC, Lara PP, Alltop LB, Breese GR: Effects of thyrotropin-releasing hormone in depression. Lancet 1972;ii:999-1002.
22. Bianchi M, Moser C, Lazzarini C, Vecchiato E, Crespi F: Forced swimming test and fluxetine treatment: in vivo evidence that peripheral 5-HT in rat platelet-rich plasma mirrors cerebral extracellular 5-HT levels, whilst 5-HT in isolated platelets mirrors neuronal 5-HT changes. Exp Brain Res 2002;143:191-197.
23. Muck-Šeler D, Jakovljević M, Pivac N: Platelet 5-HT concentrations and suicidal behaviour in recurrent major depression. J Affect Disord 1996;39:73-80.
24. Muck-Seler D, Pivac N, Sagud M, Mustapic M, Jakovljevic M: The effects of serotonin uptake inhibitors on platelet serotonin: from basic to clinical research; in Shirley AC (ed): Trends in Serotonin Uptake Inhibitors Research. New York, Nova Science, 2005, pp 29-53.
25. Muck-Seler D, Pivac N, Jakovljević M: Sex differences, season of birth and platelet 5-HT levels in schizophrenic patients. J Neural Transm 1999;106:337-347.
26. Pivac N, Muck-Seler D, Mustapic M, Sagud M, Darko Marcinko D, Deẑeljin M, Jakovljevic M: Peripheral biological markers and treatment response in schizophrenia; in French DP (ed): Schizophrenic Psychology: New Research. New York, Nova Science, 2006, pp. 319-370.
27. Blardi P, Palazzuoli A, de Lalla A, Auteri A: Variations of peripheral markers of serotoninergic system in selected vascular patients. Nutr Metab Cardiovasc Dis 2006;16:210-214.
28. Fogel WA, Lewinski A, Jochem J: Histamine in food: is there anything to worry about? Biochem Soc Trans 2007;35:349-352.
29. Fetkovska N: Platelet activation by low-density lipoprotein and serotonin: the effects of calcium antagonists. J Cardiovasc Pharmacol 1992;19:S25-S28.
30. Oreland L, Hallman J, Damberg M: Platelet MAO and personality-function and dysfunction. Curr Med Chem 2004;11:2007-2016.
31. Fagervall I, Ross SB: A and B forms of monoamine oxidase within the monoaminergic neurons of the rat brain. J Neurochem 1986;47:569-576.
32. Licata G, Davi G, Scaglione R, Dichiara MA, Catalano I, Strano A: Platelet function in hypo- and hyperthyroidism. Boll Soc Ital Biol Sper 1989;65:847-852.
33. Ford HC, Carter JM: Moderate, chronic hypothyroidism does not lead to more smallsized platelets in the circulation. Thromb Haemost 1988;60:524.
34. Coban E, Yazicioglu G, Ozdogan M: Platelet activation in subjects with subclinical hypothyroidism. Med Sci Monit 2007;13:211-214.
35. Guimaraes V, DeGroot LJ: Moderate hypothyroidism in preparation for whole body 131 I scintiscans and thyroglobulin testing. Thyroid 1996;6:69-73.
36. Mück-Šeler D, Pivac N, Sagud M, Jakovljevic M, Mihaljevic-Peleš A: The effects of paroxetine and tianeptine on peripheral biochemical markers in major depression. Prog Neuropsychopharmacol Biol Psychiatry 2002;26:1235-1243.
37. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
38. Mueller-Oerlinghausen B, Roggenbach J, Franke L: Serotonergic platelet markers of suicidal behaviour - do they really exist? J Affect Disord 2004;79:13-24.
39. Pivac N, Kozarić-Kovacić D, Mustapić M, Deẑeljin M, Nenadić-Šviglin K, Muck-Šeler D: New research on alcohol abuse and alcoholism: peripheral biological markers in alcoholism; in Walcott TA (ed): Drug and Alcohol Abuse Research Focus. New York, Nova Science, 2007, pp 1-62.
40. Ljubicic D, Stipcevic T, Pivac N, Jakovljevic M, Muck-Seler D: The influence of daylight exposure on platelet 5-HT levels in patients with major depression and schizophrenia. J Photochem Photobiol B 2007;89:63-69.
41. Rasgon N, McGuire M, Tanavoli S, Fairbanks L, Rapkin A: Neuroendocrine response to an intravenous L-tryptophan challenge in women with premenstrual syndrome. Fertil Steril 2000;73:144-149.
42. Leibenluft E, Fiero PL, Rubinow DR: Effects of menstrual cycle on dependent variables in mood disorder research. Arch Gen Psychiatry 1994;51:761-781.
43. Guicheney P, Leger D, Barrat J, Trevoux R, De Lignieres B, Roques P, Garnier JP, Boyers, P, Grenier J, Dreux C, Meyer P: Platelet serotonin content and plasma tryptophan in peri- and post-menopausal women: variations with plasma estrogen levels and depressive symptoms. Eur J Clin Invest 1988;18:297-304.
44. Muck-Seler D, Pivac N, Mustapic M, Crncevic Z, Jakovljevic M, Sagud M: Platelet serotonin and plasma prolactin and cortisol in healthy, depressed and schizophrenic women. Psychiatry Res 2004;127:217-226.
45. Vaccari A, Biassoni R, Timiras P: Selective effects of neonatal hypothyroidism on monoamine oxidase activities in the rat brain. J Neurochem 1983;40:1019-1025.
46. Oreland L: Platelet monoamine oxidase, personality and alcoholism: the rise, fall and resurrection. Neurotoxicology 2004;25:79-89.
47. Nishi K, Mück-Šeler D, Hasegawa S, Watanabe A, Diksic M: Acute effects of moclobemide and deprenyl on 5-HT synthesis rates in the rat brain: an autoradiographic study. Brain Res Bull 2006;70:368-377.
48. Denicoff KD, Joffe RT, Lakshmanan MC, Robbins J, Rubinow DR: Neuropsychiatric manifestations of altered thyroid state. Am J Psychiatry 1990;147:94-99.
49. Berrios GE, Leysen A, Samuel C, Dowson J: Psychiatric morbidity following total and partial thyroidectomy. Acta Psychiatr Scand 1985;72:369-373.
50. Montero-Pedrazuela A, Venero C, Lavado-Autric R, Fernandez-Lamo I, Garcia-Verdugo JM, Bernal J: Modulation of adult hippocampal neurogenesis by thyroid hormones: implications in depressive-like behavior. Mol Psychiatr 2006;11:361-371.
51. Tejani-Butt SM, Yang J, Kaviani A: Time course of altered thyroid states on 5-HT1A receptors and 5-HT uptake sites in rat brain: an autoradiographic analysis. Neuroendocrinology 1993;57:1011-1018.